Prognostic significance of hyperfibrinogenemia in patients with lower-risk myelodysplastic syndromes

Ann Hematol. 2020 Jan;99(1):189-191. doi: 10.1007/s00277-019-03863-z. Epub 2019 Nov 26.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Disease-Free Survival
  • Female
  • Fibrinogen / metabolism*
  • Humans
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / blood*
  • Myelodysplastic Syndromes / mortality*
  • Retrospective Studies
  • Survival Rate

Substances

  • Fibrinogen